Market Cap

SymBio Pharmaceuticals Ltd Market Capitalization:

¥8.06 Billion

JPY as of July 1, 2024

US$49.9 Million

business SymBio Pharmaceuticals Ltd Company Profile

SymBio Pharmaceuticals Ltd Main Stock Listing

JPX: 4582

Market Capitalization History of SymBio Pharmaceuticals Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of SymBio Pharmaceuticals Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 ¥9.84 B -59.96%
Jan. 1, 2023 ¥24.57 B -37.97%
Jan. 1, 2022 ¥39.61 B 45.80%
Jan. 1, 2021 ¥27.17 B 18.97%
Jan. 1, 2020 ¥22.84 B -18.08%
Jan. 1, 2019 ¥27.87 B -25.00%
Jan. 1, 2018 ¥37.17 B -2.48%
Jan. 1, 2017 ¥38.11 B 29.41%
Jan. 1, 2016 ¥29.45 B -44.01%
Jan. 1, 2015 ¥52.60 B 0.30%
Jan. 1, 2014 ¥52.44 B -34.96%
Jan. 1, 2013 ¥80.63 B 51.48%
Jan. 1, 2012 ¥53.23 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

SymBio Pharmaceuticals Ltd Categories

Japan languages Healthcare languages Drug Manufacturers—Specialty & Generic
Japan Healthcare Japan Drug Manufacturers—Specialty & Generic

Stocks & Indices

SymBio Pharmaceuticals Ltd has the following listings and related stock indices.


Stock: JPX: 4582

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.